Investigation of active form of catalytic antibody light chain 41S-2-L

被引:8
作者
Mitsuda, Y
Tsuruhata, K
Hifumi, E
Takagi, M
Uda, T
机构
[1] Hiroshima Prefectural Hosp, Sch Biosci, Shobara, Hiroshima 7270023, Japan
[2] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan
[3] Japan Adv Inst Sci & Technol, Tatsunokuchi, Ishikawa 9231292, Japan
关键词
catalytic antibody; serine protease; catalytic triad; fluorescence; aggregate;
D O I
10.1016/j.imlet.2004.07.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have raised a monoclonal antibody (41 S-2) against the conserved sequence, RGPDRPEGIEEEGGERDRD. of human immunodeficiency virus type1 (HIV-1) envelope gp41. That antibody light chain (41S-2-L) cleaves gp41-derived peptide (TPRGPDRPEGIEEEGGERDRD: TP41-1) with a characteristic biphasic profile composed of induction and active phases. It is considered that the conformation of 41S-2-L is changed, by such as induced fitting, to move to active phase to decompose the antigenic peptide during the induction phase. In order to investigate what happens to 41S-2-L in the induction and active phase, the cleavage reaction of the peptide by 41S-2-L was examined in detail from the viewpoint of kinetic and spectroscopic analysis. The kinetic data showed that the preferable conformational transition of 41S-2-L took place by the unimolecular reaction of 41S-2-L in the induction phase. UV-vis and fluorescence spectroscopic analysis suggested that the conformational transition leads to the generation of aggregates of 41S-2-L in the reacting solution. which causes the huge enhancement of the catalytic activity of 41S-2-L. The nuclei of the aggregates may be formed in the induction phase. The aggregates and soluble 41S-2-L are considered to be in chemical equilibrium during the cleavage reaction of the antigen. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 21 条
[1]   Antibody domain exchange is an immunological solution to carbohydrate cluster recognition [J].
Calarese, DA ;
Scanlan, CN ;
Zwick, MB ;
Deechongkit, S ;
Mimura, Y ;
Kunert, R ;
Zhu, P ;
Wormald, MR ;
Stanfield, RL ;
Roux, KH ;
Kelly, JW ;
Rudd, PM ;
Dwek, RA ;
Katinger, H ;
Burton, DR ;
Wilson, IA .
SCIENCE, 2003, 300 (5628) :2065-2071
[2]   Endopeptidase character of monoclonal antibody i41-7 subunits [J].
Hatiuchi, K ;
Hifumi, E ;
Mitsuda, Y ;
Uda, T .
IMMUNOLOGY LETTERS, 2003, 86 (03) :249-257
[3]   Catalytic features of monoclonal antibody i41SL1-2 subunits [J].
Hifumi, E ;
Kondo, H ;
Mitsuda, Y ;
Uda, T .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 84 (04) :485-493
[4]   Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain [J].
Hifumi, E ;
Mitsuda, Y ;
Ohara, K ;
Uda, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 269 (1-2) :283-298
[5]   Removal of catalytic activity by EDTA from antibody light chain [J].
Hifumi, E ;
Ohara, K ;
Niimi, Y ;
Uda, T .
BIOMETALS, 2000, 13 (04) :289-294
[6]   Super catalytic antibody [I]: Decomposition of targeted protein by its antibody light chain [J].
Hifumi, E ;
Okamoto, Y ;
Uda, T .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 1999, 88 (03) :323-327
[7]   How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1 [J].
Hifumi, E ;
Okamoto, Y ;
Uda, T .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2000, 83 (1-3) :209-219
[8]   Antibody multispecificity mediated by conformational diversity [J].
James, LC ;
Roversi, P ;
Tawfik, DS .
SCIENCE, 2003, 299 (5611) :1362-1367
[9]   DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers [J].
Kanyshkova, TG ;
Semenov, DV ;
Khlimankov, DY ;
Buneva, VN ;
Nevinsky, GA .
FEBS LETTERS, 1997, 416 (01) :23-26
[10]   Catalytic activity of antibodies against factor VIII in patients with hemophilia A [J].
Lacroix-Desmazes, S ;
Moreau, A ;
Sooryanarayana ;
Bonnemain, C ;
Stieltjes, N ;
Pashov, A ;
Sultan, Y ;
Hoebeke, J ;
Kazatchkine, MD ;
Kaveri, SV .
NATURE MEDICINE, 1999, 5 (09) :1044-1047